Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 14 peer-reviewed journal articles Updated
Immunology

Cracking the Code: Understanding Your HAE Lab Reports

At a Glance

A Hereditary Angioedema (HAE) diagnosis relies on specific blood tests, primarily Complement C4 and C1-INH. Measuring both the amount and function of C1-INH, alongside genetic testing when necessary, is essential for confirming your exact HAE subtype and receiving the correct treatment.

Deciphering the lab reports for Hereditary Angioedema (HAE) can feel like learning a new language. However, understanding these numbers is the only way to confirm your diagnosis and ensure you receive the correct treatment [1][2]. Because HAE is rare, standard lab tests often miss it unless your doctor specifically orders an “HAE panel” [3].

The Initial Red Flag: Complement C4

The first marker doctors usually look at is Complement C4 [1]. C4 is a protein that is “consumed” or used up when the biological pathways that cause HAE are overactive [3][4].

  • In Type 1 and Type 2 HAE: C4 levels are almost always low, especially during an attack [5]. A low C4 level is often the first clue that leads a doctor to suspect HAE [2].
  • The “Normal” Trap: It is important to know that C4 can sometimes be in the normal range between attacks or if you have a concurrent infection (which can artificially raise C4 levels) [6][7]. If your C4 is normal but your symptoms strongly suggest HAE, further testing is still required [4].

Quantity vs. Quality: The C1-INH Tests

To determine your specific HAE type, doctors measure the C1-esterase inhibitor (C1-INH) in two different ways: Antigenic and Functional [8][9].

  1. C1-INH Antigenic (Quantity): This measures the amount of the protein in your blood. Think of this as counting how many “brakes” you have in your system.
  2. C1-INH Functional (Quality): This measures how well the protein works. Think of this as testing if those “brakes” can actually stop a car.

Your Lab Result Checklist

You can use the following table to help identify your subtype based on your lab report:

Test Type 1 HAE Type 2 HAE HAE-nC1-INH
C4 Level Low [8] Low [2] Normal [10]
C1-INH Antigen (Level) Low [8] Normal or High [9] Normal [11]
C1-INH Function Low [8] Low [9] Normal [11]

When is Genetic Testing Necessary?

While most cases of Type 1 and Type 2 HAE can be diagnosed with the blood tests mentioned above, genetic testing plays a critical role in specific situations [12]:

  • Confirming HAE-nC1-INH: Since all standard blood work (C4 and C1-INH) comes back normal in this subtype, genetic testing for mutations like F12, PLG, ANGPT1, or KNG1 is often the only way to get a definitive diagnosis [10][13].
  • Family Planning: If you are planning to have children, identifying your specific SERPING1 mutation can help in screening family members early, even before they show symptoms [12]. (Because HAE is autosomal dominant, there is a 50% chance of inheritance per child).
  • Inconclusive Labs: If your symptoms are classic for HAE but your blood levels are borderline or inconsistent, genetic testing can provide the final answer [12][14].

Return to Home Page

Common questions in this guide

Why is my Complement C4 normal if I have symptoms of HAE?
C4 levels can sometimes appear normal between swelling attacks or if you have an active infection, which artificially raises the levels. If your symptoms strongly suggest HAE, further testing is still required even with a normal C4 result.
What is the difference between C1-INH antigen and functional tests?
The C1-INH antigen test measures the actual amount of the protein in your blood. The functional test measures how well that protein works to control swelling. Both tests are necessary to pinpoint your exact type of HAE.
When is genetic testing necessary for an HAE diagnosis?
While most Type 1 and Type 2 HAE cases are diagnosed with standard blood tests, genetic testing is crucial if you have normal C1-INH levels. It is also used when standard labs are inconclusive or for screening family members.
Does it matter when my blood is drawn for an HAE test?
It is often helpful to have your C4 level drawn during an active swelling attack, as this is when the protein is most depleted. Be sure to tell your doctor if you had a fever or infection when the blood was drawn, as this can affect the results.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Was my C4 level drawn during an active swelling attack or during a symptom-free period?
  2. 2.Since my C1-INH protein level (antigen) came back normal, can we specifically test the C1-INH function?
  3. 3.My C4 is low but my C1-INH tests are normal; what other conditions should we be looking for?
  4. 4.Given my normal C1-INH results but strong family history, is it time to order a genetic panel for F12, PLG, and ANGPT1 mutations?
  5. 5.Can you walk me through my lab report and explain which specific result confirms my HAE subtype?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (14)
  1. 1

    The physician and hereditary angioedema friend or foe: 62-year diagnostic delay and iatrogenic procedures.

    Valerieva A, Cicardi M, Baraniuk J, Staevska M

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2018; (14()):75 doi:10.1186/s13223-018-0275-4.

    PMID: 30386388
  2. 2

    Screening for type II hereditary angioedema-the "poor man's c1-inhibitor function".

    Jindal AK, Chiang V, Barman P, et al.

    The journal of allergy and clinical immunology. Global 2024; (3(1)):100179 doi:10.1016/j.jacig.2023.100179.

    PMID: 38026504
  3. 3

    HAE patient self-sampling for biomarker establishment.

    Förster TM, Magerl M, Maurer M, et al.

    Orphanet journal of rare diseases 2021; (16(1)):399 doi:10.1186/s13023-021-02021-x.

    PMID: 34583739
  4. 4

    Hereditary angioedema diagnosis: Reflecting on the past, envisioning the future.

    Grumach AS, Riedl MA, Cheng L, et al.

    The World Allergy Organization journal 2025; (18(6)):101060 doi:10.1016/j.waojou.2025.101060.

    PMID: 40487881
  5. 5

    Misdiagnosed Hereditary Angioedema with Recurrent Abdominal Pain: A Novel SERPING1 Frameshift Variant.

    Xie R, Wen R, Li Y, et al.

    Journal of asthma and allergy 2025; (18()):1367-1375 doi:10.2147/JAA.S536943.

    PMID: 41084504
  6. 6

    The role of C1 inhibitor and complement as acute phase reactants: are we missing the diagnosis of hereditary angioedema?

    Stepaniuk P, Bosonea AM, Pourshahnazari P, et al.

    Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology 2021; (17(1)):103 doi:10.1186/s13223-021-00607-5.

    PMID: 34627363
  7. 7

    Urgent diagnosis of hereditary angioedema in the ICU and ED: the critical role of rapid complement testing - a case report.

    Dungan LS, Khalib K, Curley D, Keogan M

    International journal of emergency medicine 2025; (18(1)):254 doi:10.1186/s12245-025-01057-1.

    PMID: 41339791
  8. 8

    Hereditary angioedema (HAE) in children and adolescents: New treatment options.

    Fasshauer M, Wedi B

    Allergologie select 2024; (8()):336-345 doi:10.5414/ALX02532E.

    PMID: 39502954
  9. 9

    Medical algorithm: Management of C1 inhibitor hereditary angioedema.

    Caballero T, Cabañas R, Pedrosa M

    Allergy 2022; (77(3)):1060-1063 doi:10.1111/all.15115.

    PMID: 34587298
  10. 10

    Angioedema without urticaria: Diagnosis and management.

    Young MC, Banerji A

    Allergy and asthma proceedings 2025; (46(3)):185-191 doi:10.2500/aap.2025.46.250013.

    PMID: 40380367
  11. 11

    Hereditary angioedema with normal C1 esterase inhibitor: Current paradigms and clinical dilemmas.

    Radojicic C, Anderson J

    Allergy and asthma proceedings 2024; (45(3)):147-157 doi:10.2500/aap.2024.45.240010.

    PMID: 38755781
  12. 12

    Identification of an elusive SERPING1 deletion in a family with hereditary angioedema type I utilizing soft clipping.

    Wetherby K, Chiao J, Faulkner E, et al.

    Frontiers in allergy 2025; (6()):1565283 doi:10.3389/falgy.2025.1565283.

    PMID: 40313637
  13. 13

    Biochemistry, molecular genetics, and clinical aspects of hereditary angioedema with and without C1 inhibitor deficiency.

    Miyata T, Horiuchi T

    Allergology international : official journal of the Japanese Society of Allergology 2023; (72(3)):375-384 doi:10.1016/j.alit.2023.04.004.

    PMID: 37169642
  14. 14

    Recognition and Management of Hereditary Angioedema: Best Practices for Dermatologists.

    Manning ME

    Dermatology and therapy 2021; (11(5)):1829-1838 doi:10.1007/s13555-021-00593-x.

    PMID: 34460082

This page explains Hereditary Angioedema (HAE) lab testing for educational purposes. Always consult your immunologist or healthcare provider to accurately interpret your specific lab results and diagnosis.

Get notified when new evidence is published on Hereditary angioedema.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.